Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Auxilium Pharmaceuticals Inc reaffirms FY 2013 revenue guidance - Conference Call

Wednesday, 15 Jan 2014 07:00pm EST 

Auxilium Pharmaceuticals Inc:Says it is comfortable with the guidance that it has given for FY 2013, which would result in revenues of somewhere in the range of $370 million to $400 million.FY 2013 revenue of $387 million - Thomson Reuters I/B/E/S. 

Company Quote

-0.11 -0.32%
25 Nov 2014